Boston Scientific Sets $2 Billion Accelerated Stock Buyback

Published: 2026-05-18 07:43:22 ET BSX

Published on 05/18/2026 at 07:43 am EDT - Modified on 05/18/2026 at 07:44 am EDT

By Colin Kellaher

Boston Scientific has signed a $2 billion accelerated share-repurchase agreement with JPMorgan Chase as part of the medical-technology company's $5 billion stock-buyback program.

Boston Scientific on Monday said it expects an initial delivery of about 30.4 million shares, representing about 80% of the stock covered by the agreement, adding that it expects to complete the accelerated buyback by June 30.

The Marlborough, Mass., company, which had nearly 1.49 billion shares outstanding as of April 29, sports a market capitalization topping $78 billion.

Boston Scientific said it will still have $3 billion available under its share-repurchase authorization upon completion of the accelerated buyback.

Write to Colin Kellaher at [email protected]

(END) Dow Jones Newswires

05-18-26 0742ET